Entero Therapeutics Other Current Liabilities

Entero Therapeutics (ENTO) currently reports a other current liabilities of $9.7M as of March 2026. That compares with $25M in the prior-year period — down 61.4% year over year. Use the charts on this page to explore Entero Therapeutics's other current liabilities history and peer comparisons.

Entero Therapeutics's other current liabilities decreased from $25M to $9.7M — a 61.4% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Entero Therapeutics reported $9.7M in other current liabilities as of March 2026. That compares with $25M in the prior-year period — down 61.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $9.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Entero Therapeutics, and consider following ENTO for alerts when major investors trade the stock.